Alnylam Pharmaceuticals
ALNY
#647
Rank
$30.35 B
Marketcap
$235.31
Share price
-0.30%
Change (1 day)
20.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company